Clinical Trial Update: A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating the interaction of lovastatin and paclitaxel in patients with refractory or relapsed ovarian cancer; study terminated with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Lovastatin (Lovastatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University of Iowa | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-01-05